ITH IMMUNE THERAPY HOLDINGS AB has a total of 44 patent applications. Its first patent ever was published in 2006. It filed its patents most often in EPO (European Patent Office), China and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and medical technology are UNIV OKAYAMA NAT UNIV CORP, UNIV COLLEGE CARDIFF CONSULTANTS LTD and ETS FRANCAIS DU SANG.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 8 | |
#2 | China | 7 | |
#3 | Australia | 4 | |
#4 | WIPO (World Intellectual Property Organization) | 4 | |
#5 | Canada | 3 | |
#6 | EAPO (Eurasian Patent Organization) | 3 | |
#7 | Republic of Korea | 3 | |
#8 | South Africa | 3 | |
#9 | Israel | 2 | |
#10 | Singapore | 2 | |
#11 | Brazil | 1 | |
#12 | India | 1 | |
#13 | Mexico | 1 | |
#14 | Slovenia | 1 | |
#15 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Medical technology | |
#4 | Chemical engineering | |
#5 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Syringes | |
#6 | Chemical or physical processes | |
#7 | Microbiology | |
#8 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Winqvist Ola | 29 |
#2 | Cotton Graham | 11 |
#3 | Gabrielsson Susanne | 9 |
#4 | Thorn Magnus | 6 |
#5 | Thoern Magnus | 5 |
#6 | Ola Winqvist | 3 |
#7 | Magnus Thoern | 2 |
#8 | Thörn Magnus | 2 |
#9 | Larsson Patrik | 1 |
#10 | Karlsson Mikael C I | 1 |
Publication | Filing date | Title |
---|---|---|
CN103857421A | Treating cancer | |
EP2718723A1 | Diagnosing and treating inflammatory bowel disease and irritable bowel syndrome | |
CN103796693A | Treating conditions associated with metabolic syndrome | |
AU2011202946A1 | Method and means for treating inflammatory bowel disease | |
CN102470167A | Exosome based treatment of cancer | |
CN102186880A | Treating inflammatory conditions | |
EP2331116A1 | Anti-infective compounds and uses thereof | |
AU2008283077A1 | Diagnosis, staging and monitoring of inflammatory bowel disease | |
EP2183596A1 | Method and means for prediction of systemic lupus erythematosus susceptibility | |
EP2043663A1 | Topical treatment of warts | |
CN101252941A | Treatment of inflammatory bowel disease |